HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection

被引:43
作者
Gao, Xiaojiang [1 ,4 ]
O'Brien, Thomas R. [2 ]
Welzel, Tania M. [2 ]
Marti, Darlene [1 ,4 ]
Qi, Ying [1 ,4 ]
Goedert, James J. [2 ]
Phair, John [3 ]
Pfeiffer, Ruth [2 ]
Carrington, Mary [1 ,4 ]
机构
[1] SAIC Frederick Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA
[2] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[3] Northwestern Univ, Sch Med, Chicago, IL USA
[4] MIT & Harvard, Ragon Inst MGH, Boston, MA USA
基金
美国国家卫生研究院;
关键词
AIDS; AIDS progression; HIV; HIV transmission; human leukocyte antigen; MHC diversity; viral load; IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSFUSION RECIPIENTS; RNA LEVELS; PLASMA; COUPLES; RISK;
D O I
10.1097/QAD.0b013e32833c3219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: HLA class I polymorphism is known to affect the rate of progression to AIDS after infection with HIV-1. Here we test the consistency of HLA-B allelic effects on progression to AIDS, heterosexual HIV transmission, and 'set point' viral levels. Methods: We used adjusted Cox proportional hazard models in previously published relative hazard values for the effect of HLA-B alleles on progression to AIDS (n = 1089). The transmission study included 303 HIV-1-infected men with hemophilia and their 323 female sex partners (Multicenter Hemophilia Cohort Study cohort). Among 259 HIV-1 seroconverters (Multicenter AIDS Cohort Study cohort), HIV RNA levels at 'set point' were determined in stored plasma samples by a reverse-transcription polymerase chain reaction assay. HLA-B genotyping was performed by sequence-specific oligonucleotide hybridization and DNA sequencing. Results: Several HLA-B alleles showed consistent associations for AIDS risk, infectivity, and 'set point' HIV RNA. HLA-B*35 was associated with more rapid progression to AIDS (relative hazard 1.39; P = 0.008), greater infectivity (odds ratio 3.14; P = 0.002), and higher HIV RNA (P = 0.01), whereas the presence of either B*27 or B*57 associated with slower progression to AIDS (B*27: relative hazard 0.49, P< 0.001; B*57: relative hazard 0.40, P< 0.0001), less infectivity (odds ratio 0.22 and 0.31, respectively, though not significant), and lower viral levels (P< 0.0001). Importantly, HLA-B polymorphism in female partners was not associated with susceptibility to HIV-1 infection. Conclusion: HLA-B polymorphisms that affect the risk of AIDS may also alter HIV-1 infectivity, probably through the common mechanism of viral control, but they do not appear to protect against infection in our cohort. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1835 / 1840
页数:6
相关论文
共 23 条
[1]   Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection [J].
Altfeld, M ;
Addo, MA ;
Rosenberg, ES ;
Hecht, FA ;
Lee, PK ;
Vogel, M ;
Yu, XG ;
Draenert, R ;
Johnston, MN ;
Strick, D ;
Allen, TA ;
Feeney, ME ;
Kahn, JO ;
Sekaly, RP ;
Levy, JA ;
Rockstroh, JK ;
Goulder, PJR ;
Walker, BD .
AIDS, 2003, 17 (18) :2581-2591
[2]   The influence of HLA genotype on AIDS [J].
Carrington, M ;
O'Brien, SJ .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :535-551
[3]   A whole-genome association study of major determinants for host control of HIV-1 [J].
Fellay, Jacques ;
Shianna, Kevin V. ;
Ge, Dongliang ;
Colombo, Sara ;
Ledergerber, Bruno ;
Weale, Mike ;
Zhang, Kunlin ;
Gumbs, Curtis ;
Castagna, Antonella ;
Cossarizza, Andrea ;
Cozzi-Lepri, Alessandro ;
De Luca, Andrea ;
Easterbrook, Philippa ;
Francioli, Patrick ;
Mallal, Simon ;
Martinez-Picado, Javier ;
Miro, Jose M. ;
Obel, Niels ;
Smith, Jason P. ;
Wyniger, Josiane ;
Descombes, Patrick ;
Antonarakis, Stylianos E. ;
Letvin, Norman L. ;
McMichael, Andrew J. ;
Haynes, Barton F. ;
Telenti, Amalio ;
Goldstein, David B. .
SCIENCE, 2007, 317 (5840) :944-947
[4]   AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis [J].
Gao, XJ ;
Bashirova, A ;
Iversen, AKN ;
Phair, J ;
Goedert, JJ ;
Buchbinder, S ;
Hoots, K ;
Vlahov, D ;
Altfeld, M ;
O'Brien, SJ ;
Carrington, M .
NATURE MEDICINE, 2005, 11 (12) :1290-1292
[5]   Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. [J].
Gao, XJ ;
Nelson, GW ;
Karacki, P ;
Martin, MP ;
Phair, J ;
Kaslow, R ;
Goedert, JJ ;
Buchbinder, S ;
Hoots, K ;
Vlahov, D ;
O'Brien, SJ ;
Carrington, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1668-1675
[6]   Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 [J].
Gillespie, GMA ;
Kaul, R ;
Dong, T ;
Yang, HB ;
Rostron, T ;
Bwayo, JJ ;
Kiama, P ;
Peto, T ;
Plummer, FA ;
McMichael, AJ ;
Rowland-Jones, SL .
AIDS, 2002, 16 (07) :961-972
[7]   A PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION AND THE DEVELOPMENT OF AIDS IN SUBJECTS WITH HEMOPHILIA [J].
GOEDERT, JJ ;
KESSLER, CM ;
ALEDORT, LM ;
BIGGAR, RJ ;
ANDES, WA ;
WHITE, GC ;
DRUMMOND, JE ;
VAIDYA, K ;
MANN, DL ;
EYSTER, ME ;
RAGNI, MV ;
LEDERMAN, MM ;
COHEN, AR ;
BRAY, GL ;
ROSENBERG, PS ;
FRIEDMAN, RM ;
HILGARTNER, MW ;
BLATTNER, WA ;
KRONER, B ;
GAIL, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1141-1148
[8]   Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses [J].
Kelleher, AD ;
Long, C ;
Holmes, EC ;
Allen, RL ;
Wilson, J ;
Conlon, C ;
Workman, C ;
Shaunak, S ;
Olson, K ;
Goulder, P ;
Brander, C ;
Ogg, G ;
Sullivan, JS ;
Dyer, W ;
Jones, I ;
McMichael, AJ ;
Rowland-Jones, S ;
Phillips, RE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) :375-385
[9]   Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma [J].
Kirstein, LM ;
Mellors, JW ;
Rinaldo, CR ;
Margolick, JB ;
Giorci, JV ;
Phair, JP ;
Dietz, E ;
Gupta, P ;
Sherlock, CH ;
Hogg, R ;
Montaner, JSG ;
Muñoz, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) :2428-2433
[10]   NK cell recognition [J].
Lanier, LL .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :225-274